Bone loss: Factors that regulate osteoclast differentiation - an update

AUTOR(ES)

Roux, Sophie

FONTE

BioMed Central

RESUMO

Osteoclast activation is a critical cellular process for pathological bone resorption, such as erosions in rheumatoid arthritis (RA) or generalized bone loss. Among many factors triggering excessive osteoclast activity, cytokines such as IL-1 or tumour necrosis factor (TNF)-α play a central role. New members of the TNF receptor ligand family (namely receptor activator of nuclear factor-κB [RANK] and RANK ligand [RANKL]) have been discovered whose cross-interaction is mandatory for the differentiation of osteoclasts from hemopoietic precursors, in both physiological and pathological situations. Osteoprotegerin, a decoy receptor which blocks this interaction, decreases osteoclast activity and could have a fascinating therapeutic potential in conditions associated with upregulated bone resorption.

Documentos Relacionados

• Bone loss: Epidemiology of bone loss
• Bone loss: Therapeutic approaches for preventing bone loss in inflammatory arthritis
• Bone loss: Quantitative imaging techniques for assessing bone mass in rheumatoid arthritis
• Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro.
• Loss of Cbl-b Increases Osteoclast Bone-Resorbing Activity and Induces Osteopenia